Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BSX

Boston Scientific Corporation

Healthcare | Medical - Devices
$48.37 as of 2026-09-03 10:25 UTC
Market Cap$71.9B
Volume17.01M
EPS (TTM)$1.94

Boston Scientific Corporation (NYSE: BSX) is a $71.9B medical - devices company trading at $48.37 — 24.9× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-03 10:25 UTC.

52-Week Range
Low $42.20High $61.73

What Boston Scientific Corporation does

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions. The company operates through two reportable segments: MedSurg, which includes endoscopy, urology and neuromodulation businesses, and Cardiovascular, which focuses on interventional cardiology and vascular therapies.

Summarized from Boston Scientific Corporation’s SEC filings · Read the filing ↗

Key facts

Quote
Price$48.37
Market cap$71.9B
Volume17.01M shares
52-week range$42.20 – $61.73
Valuation
P/E (TTM)24.93×
EV/EBITDA14.10×
EPS (TTM)$1.94
Price/book2.97×
Return on equity11.96%
Debt/equity0.01
Returns
52-week return+14.6%

Operating Metrics

How we read this →

Boston Scientific Corp. (BSX) reported 2 operating metrics for Q1 2026 in its SEC earnings exhibit filed 2026-04-22.

Most recent reported period: Q1 2026, filed 2026-04-22.

Segment revenue$5.20B

See how BSX compares across the industry →

Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗

Growth rates

How we read this →
Revenue growth+11.6%

Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.

Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗

Revenue, margins & earnings

FY2021 Net income: $985MFY2021 Taxes & interest: $214MFY2021 Operating expenses: $6.98BFY2021 Cost of revenue: $3.71B$11.9BFY2021FY2022 Net income: $642MFY2022 Taxes & interest: $1.01BFY2022 Operating expenses: $7.08BFY2022 Cost of revenue: $3.96B$12.7BFY2022FY2023 Net income: $1.57BFY2023 Taxes & interest: $773MFY2023 Operating expenses: $7.55BFY2023 Cost of revenue: $4.34B$14.2BFY2023FY2024 Net income: $1.85BFY2024 Taxes & interest: $750MFY2024 Operating expenses: $8.89BFY2024 Cost of revenue: $5.26B$16.7BFY2024FY2025 Net income: $2.90BFY2025 Taxes & interest: $715MFY2025 Operating expenses: $10.2BFY2025 Cost of revenue: $6.22B$20.1BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
Net income for FY2021, FY2022, FY2023, FY2024, FY2025 is the filer’s available-to-common figure (net of preferred dividends) — the filer tags no parent net income for those years.

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-26
  • 2026-08-26Morano Susan EBUY2,040$100.4K
  • 2026-08-12Woodworth EmilySVP, Global Controller and CAOI2,930$150.0K
  • 2026-08-11Monson JonathanEVP and CFOI9,908$500.0K
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does Boston Scientific Corporation do?

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions.

What is BSX's valuation?

BSX trades at $48.37, 24.93× trailing earnings, 14.10× EV/EBITDA, as of 2026-09-03.

When did BSX last file with the SEC?

Boston Scientific Corporation's most recent SEC filing on record is a 8-K filed 2026-05-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-03 10:25 UTC. This page is also available as JSON at /api/data?ticker=BSX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BSX and 5,000+ tickers.

Create a free account — keep BSX
For your agent
GET /api/data?ticker=BSX

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt